Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Delayed Data from NYSE)

$16.81 USD

16.81
614,941

-0.10 (-0.59%)

Updated Sep 23, 2022 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.63%
2Buy18.00%
3Hold9.55%
4Sell5.25%
5Strong Sell2.32%
S&P50010.82%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (154 out of 251)

Industry: Medical Services

Trades from $1

Balance Sheet

Research for MD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Pediatrix Medical Group, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 487 1,229 187 79 70
Receivables 316 242 499 542 504
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 37 79 45 36 53
Total Current Assets 841 1,549 732 657 627
Net Property & Equipment 70 76 94 133 124
Investments & Advances 0 0 0 70 81
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 88 54 162 0 0
Intangibles 1,527 1,505 2,985 4,971 4,924
Deposits & Other Assets 131 107 90 103 112
Total Assets 2,723 3,348 4,146 5,935 5,867
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 0 0 0 0 0
Accounts Payable 394 423 512 469 438
Current Portion Long-Term Debt 2 2 0 0 1
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 11 0 7 31 92
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 427 444 542 500 531
Mortgages 0 0 0 0 0
Deferred Taxes/Income 41 62 58 131 148
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,002 1,743 1,730 1,974 1,851
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 313 311 250 241 270
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,826 2,600 2,647 2,847 2,801
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,050 1,029 988 993 1,017
Retained Earnings -155 -286 510 2,094 2,048
Other Equity 2 4 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 897 748 1,499 3,088 3,066
Total Liabilities & Shareholder's Equity 2,723 3,348 4,146 5,935 5,867
Total Common Equity 897 748 1,499 3,088 3,066
Shares Outstanding 86.40 85.60 84.30 89.40 93.60
Book Value Per Share 10.38 8.74 17.78 34.54 32.76

Fiscal Year End for Pediatrix Medical Group, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Assets          
Cash & Equivalents 107 97 487 456 439
Receivables 329 318 316 279 277
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 23 25 37 52 36
Total Current Assets 459 440 841 788 752
Net Property & Equipment 72 72 70 73 68
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 93 85 88 72 56
Intangibles 1,553 1,550 1,527 1,518 1,507
Deposits & Other Assets 124 128 131 130 114
Total Assets 2,370 2,341 2,723 2,646 2,555
Liabilities & Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Notes Payable 0 0 0 0 0
Accounts Payable 287 232 394 376 330
Current Portion Long-Term Debt 15 2 2 3 2
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 6 14 11 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 329 270 427 398 351
Mortgages 0 0 0 0 0
Deferred Taxes/Income 43 39 41 51 48
Convertible Debt 0 0 0 0 0
Long-Term Debt 793 805 1,002 1,003 997
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 316 313 309 310
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,524 1,464 1,826 1,800 1,746
Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 997 1,054 1,050 1,045 1,039
Retained Earnings -149 -177 -155 -203 -234
Other Equity -3 -1 2 2 3
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 845 877 897 846 809
Total Liabilities & Shareholder's Equity 2,370 2,341 2,723 2,646 2,555
Total Common Equity 845 877 897 846 809
Shares Outstanding 84.30 87.20 86.40 86.40 86.30
Book Value Per Share 10.03 10.06 10.38 9.79 9.38